Biosynthesis of heme in mammals.
暂无分享,去创建一个
[1] N. Andrews,et al. A mouse model of familial porphyria cutanea tarda. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[2] H. Kohno,et al. Involvement of peripheral-type benzodiazepine receptors in the intracellular transport of heme and porphyrins. , 1995, Journal of biochemistry.
[3] B. Grandchamp,et al. A molecular defect in coproporphyrinogen oxidase gene causing harderoporphyria, a variant form of hereditary coproporphyria. , 1995, Human molecular genetics.
[4] M. Badminton,et al. Molecular mechanisms of dominant expression in porphyria , 2005, Journal of Inherited Metabolic Disease.
[5] B. Grandchamp,et al. Homozygous hereditary coproporphyria caused by an arginine to tryptophane substitution in coproporphyrinogen oxidase and common intragenic polymorphisms. , 1994, Human molecular genetics.
[6] M. Badminton,et al. Liver transplantation as a cure for acute intermittent porphyria , 2004, The Lancet.
[7] Jiandie D. Lin,et al. Nutritional Regulation of Hepatic Heme Biosynthesis and Porphyria through PGC-1α , 2005, Cell.
[8] D. Brenner,et al. A single promoter directs both housekeeping and erythroid preferential expression of the human ferrochelatase gene. , 1994, The Journal of biological chemistry.
[9] Y. Adachi,et al. Regulation of the expression of human ferrochelatase by intracellular iron levels. , 2000, European journal of biochemistry.
[10] C. Beaumont,et al. Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. , 1996, American journal of human genetics.
[11] M. Owen,et al. Partial characterization and assignment of the gene for protoporphyrinogen oxidase and variegate porphyria to human chromosome 1q23. , 1995, Human molecular genetics.
[12] P. Giampietro,et al. Regional gene assignment of human porphobilinogen deaminase and esterase A4 to chromosome 11q23 leads to 11qter. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[13] E. Klasen,et al. Genetic aspects of erythropoietic protoporphyria , 1984, Annals of human genetics.
[14] J. Rose,et al. The 2.0 Å structure of human ferrochelatase, the terminal enzyme of heme biosynthesis , 2001, Nature Structural Biology.
[15] R. Desnick,et al. δ‐Aminolevulinic Acid Dehydratase Isozymes and Lead Toxicity a , 1987 .
[16] K. Furuyama,et al. Role of the heme regulatory motif in the heme-mediated inhibition of mitochondrial import of 5-aminolevulinate synthase. , 2004, Journal of biochemistry.
[17] M. Worwood,et al. Mutations in the hemochromatosis gene, porphyria cutanea tarda, and iron overload , 1998, Hepatology.
[18] J. Deybach,et al. Variegate porphyria in Western Europe: identification of PPOX gene mutations in 104 families, extent of allelic heterogeneity, and absence of correlation between phenotype and type of mutation. , 1999, American journal of human genetics.
[19] D. Steensma,et al. Congenital Erythropoietic Porphyria, β-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation. , 2005 .
[20] M. Mattei,et al. Assignment of human uroporphyrinogen decarboxylase (URO-D) to the p34 band of chromosome 1 , 1986, Human Genetics.
[21] J. Phillips,et al. Uroporphyria in the uroporphyrinogen decarboxylase‐deficient mouse: Interplay with siderosis and polychlorinated biphenyl exposure , 2002, Hepatology.
[22] D. Schomburg,et al. Uroporphyrinogen-III synthase , 1990 .
[23] C. Hill,et al. Crystal structure of human uroporphyrinogen decarboxylase , 1998, The EMBO journal.
[24] B. Strandvik,et al. Liver Transplantation in a Boy with Acute Porphyria Due to Aminolaevulinate Dehydratase Deficiency , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.
[25] J. Cooper,et al. X-ray structure of 5-aminolevulinic acid dehydratase from Escherichia coli complexed with the inhibitor levulinic acid at 2.0 A resolution. , 1999, Biochemistry.
[26] Dieter Jahn,et al. Crystal structure of 5‐aminolevulinate synthase, the first enzyme of heme biosynthesis, and its link to XLSA in humans , 2005, The EMBO journal.
[27] P. Meissner,et al. Allosteric inhibition of human lymphoblast and purified porphobilinogen deaminase by protoporphyrinogen and coproporphyrinogen. A possible mechanism for the acute attack of variegate porphyria. , 1993, The Journal of clinical investigation.
[28] S. Takahashi,et al. Differential regulation of coproporphyrinogen oxidase gene between erythroid and nonerythroid cells. , 1998, Blood.
[29] H. Bonkovsky,et al. Recommendations for the Diagnosis and Treatment of the Acute Porphyrias , 2005, Annals of Internal Medicine.
[30] K. Astrin,et al. Congenital erythropoietic porphyria: advances in pathogenesis and treatment , 2002, British journal of haematology.
[31] S. Sassa,et al. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone. , 1983, The Journal of clinical investigation.
[32] K. Anderson,et al. Erythropoietic protoporphyria: altered phenotype after bone marrow transplantation for myelogenous leukemia in a patient heteroallelic for ferrochelatase gene mutations. , 2002, Journal of the American Academy of Dermatology.
[33] R. Scarpulla,et al. Activation of the human mitochondrial transcription factor A gene by nuclear respiratory factors: a potential regulatory link between nuclear and mitochondrial gene expression in organelle biogenesis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Elder. Genetic defects in the porphyrias: types and significance. , 1998, Clinics in dermatology.
[35] A. Smith,et al. Decarboxylation of porphyrinogens by rat liver uroporphyrinogen decarboxylase. , 1979, The Biochemical journal.
[36] E. Cánepa,et al. Phosphatidylinositol 3-kinase and Ras/mitogen-activated protein kinase signaling pathways are required for the regulation of 5-aminolevulinate synthase gene expression by insulin. , 2001, Experimental cell research.
[37] G. Elder,et al. Alternative splicing and tissue-specific transcription of human and rodent ubiquitous 5-aminolevulinate synthase (ALAS1) genes. , 2001, Biochimica et biophysica acta.
[38] P. Martásek,et al. Structural basis of hereditary coproporphyria. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[39] K. Anderson. Disorders of heme biosynthesis : X-linked sideroblastic anemia and the porphyrias , 2001 .
[40] R. Desnick,et al. Human uroporphyrinogen-III synthase: genomic organization, alternative promoters, and erythroid-specific expression. , 2000, Genomics.
[41] E. Jaffe,et al. 5-Chlorolevulinate modification of porphobilinogen synthase identifies a potential role for the catalytic zinc. , 1992, Biochemistry.
[42] R. Desnick,et al. delta-Aminolevulinic acid dehydratase isozymes and lead toxicity. , 1987, Annals of the New York Academy of Sciences.
[43] J. Deybach,et al. Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. , 1999, Blood.
[44] J. Inazawa,et al. Structure of the human ferrochelatase gene. Exon/intron gene organization and location of the gene to chromosome 18. , 1992, European journal of biochemistry.
[45] I. Glass,et al. Molecular Genetics of Congenital Erythropoietic Porphyria , 1998, Seminars in liver disease.
[46] V. Mootha,et al. Mechanisms Controlling Mitochondrial Biogenesis and Respiration through the Thermogenic Coactivator PGC-1 , 1999, Cell.
[47] R. Errington,et al. Identification of sequences required for the import of human protoporphyrinogen oxidase to mitochondria. , 2004, The Biochemical journal.
[48] Geraint T. Williams,et al. Photosensitivity and acute liver injury in myeloproliferative disorder secondary to late-onset protoporphyria caused by deletion of a ferrochelatase gene in hematopoietic cells. , 2006, Blood.
[49] N. Carter,et al. Assignment of the human ferrochelatase gene (FECH) and a locus for protoporphyria to chromosome 18q22. , 1991, Genomics.
[50] E. Cánepa,et al. Hepatic Nuclear Factor 3 and Nuclear Factor 1 Regulate 5-Aminolevulinate Synthase Gene Expression and Are Involved in Insulin Repression* , 2004, Journal of Biological Chemistry.
[51] M. Timko,et al. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. , 1993, Science.
[52] R. Desnick,et al. Human delta-aminolevulinate dehydratase (ALAD) gene: structure and alternative splicing of the erythroid and housekeeping mRNAs. , 1994, Genomics.
[53] S. Hasnain,et al. Two different zinc sites in bovine 5-aminolevulinate dehydratase distinguished by extended X-ray absorption fine structure. , 1990, Biochemistry.
[54] H. Dailey,et al. In situ conversion of coproporphyrinogen to heme by murine mitochondria: Terminal steps of the heme biosynthetic pathway , 1993, Protein science : a publication of the Protein Society.
[55] R. Whittington,et al. Pyridoxine Responsive Anemia in the Human Adult.∗ , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[56] J. Bloomer. The liver in protoporphyria , 1988, Hepatology.
[57] Robert Huber,et al. Crystal structure of protoporphyrinogen IX oxidase: a key enzyme in haem and chlorophyll biosynthesis , 2004, The EMBO journal.
[58] D W Heinz,et al. High resolution crystal structure of a Mg2+-dependent porphobilinogen synthase. , 1999, Journal of molecular biology.
[59] J. Deybach,et al. Recovery from a variegate porphyria by a liver transplantation , 2004, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[60] D. Brenner,et al. Analysis of the human ferrochelatase promoter in transgenic mice. , 1998, Blood.
[61] J. Phillips,et al. Fast track to the porphyrias , 2005, Nature Medicine.
[62] J. Prchal,et al. Regulation of ferrochelatase gene expression by hypoxia. , 2004, Life sciences.
[63] C. Hill,et al. Crystal structure of human uroporphyrinogen III synthase , 2001, The EMBO journal.
[64] T. Rouault,et al. Iron–sulphur cluster biogenesis and mitochondrial iron homeostasis , 2005, Nature Reviews Molecular Cell Biology.
[65] T. Yoshinaga,et al. Coproporphyrinogen oxidase. II. Reaction mechanism and role of tyrosine residues on the activity. , 1980, The Journal of biological chemistry.
[66] P. Romeo,et al. Molecular cloning and nucleotide sequence of a complete human uroporphyrinogen decarboxylase cDNA. , 1986, The Journal of biological chemistry.
[67] J. Helliwell,et al. Time-resolved and static-ensemble structural chemistry of hydroxymethylbilane synthase. , 2003, Faraday discussions.
[68] H. Inokuchi,et al. Induction of terminal enzymes for heme biosynthesis during differentiation of mouse erythroleukemia cells. , 1995, European journal of biochemistry.
[69] T. Cox,et al. Transcriptional Regulation of the Human Erythroid 5-Aminolevulinate Synthase Gene , 1997, The Journal of Biological Chemistry.
[70] P. Anderson,et al. Purification and properties of delta-aminolevulinate dehydrase from human erythrocytes. , 1979, The Journal of biological chemistry.
[71] D. Richardson,et al. Iron trafficking in the mitochondrion: novel pathways revealed by disease. , 2005, Blood.
[72] F. Fougerousse,et al. Localization of the human coproporphyrinogen oxidase gene to chromosome band 3q12 , 1994, Human Genetics.
[73] C. Elferink,et al. Regulation of 5-aminolevulinate synthase mRNA in different rat tissues. , 1988, The Journal of biological chemistry.
[74] J. Phillips,et al. Hemochromatosis genes and other factors contributing to the pathogenesis of porphyria cutanea tarda. , 2000, Blood.
[75] B. Paw,et al. Deficiency of glutaredoxin 5 reveals Fe–S clusters are required for vertebrate haem synthesis , 2005, Nature.
[76] R. Desnick,et al. Uroporphyrinogen III Synthase , 2000, The Journal of Biological Chemistry.
[77] J. G. Straka,et al. Purification and characterization of bovine hepatic uroporphyrinogen decarboxylase. , 1983, Biochemistry.
[78] J. Deybach,et al. Acute intermittent porphyria: prevalence of mutations in the porphobilinogen deaminase gene in blood donors in France , 1997, Journal of internal medicine.
[79] P. Labbé,et al. Human coproporphyrinogen oxidase. Biochemical characterization of recombinant normal and R231W mutated enzymes expressed in E. coli as soluble, catalytically active homodimers. , 1997, Cellular and molecular biology.
[80] P. Labbé,et al. Crystal Structure of the Oxygen-dependant Coproporphyrinogen Oxidase (Hem13p) of Saccharomyces cerevisiae* , 2004, Journal of Biological Chemistry.
[81] P. Goodfellow,et al. Regional assignment of the human uroporphyrinogen III synthase (UROS) gene to chromosome 10q25.2→q26.3 , 2005, Human Genetics.
[82] P. Romeo,et al. Alternative transcription and splicing of the human porphobilinogen deaminase gene result either in tissue-specific or in housekeeping expression. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[83] H. Dailey,et al. Examination of mitochondrial protein targeting of haem synthetic enzymes: in vivo identification of three functional haem-responsive motifs in 5-aminolaevulinate synthase. , 2005, The Biochemical journal.
[84] M. Gross,et al. Assignment of the gene for uroporphyrinogen decarboxylase to human chromosome 1 by somatic cell hybridization and specific enzyme immunoassay , 2004, Human Genetics.
[85] Masayuki Yamamoto,et al. Differential Regulation of Coproporphyrinogen Oxidase Gene Between Erythroid and Nonerythroid Cells , 1998 .
[86] S. Takahashi,et al. Cloning of a coproporphyrinogen oxidase promoter regulatory element binding protein. , 2000, Biochemical and biophysical research communications.
[87] P. Shoolingin-Jordan,et al. Human porphobilinogen deaminase mutations in the investigation of the mechanism of dipyrromethane cofactor assembly and tetrapyrrole formation. , 2003, Biochemical Society transactions.
[88] H. Inokuchi,et al. The human protoporphyrinogen oxidase gene (PPOX): organization and location to chromosome 1. , 1995, Genomics.
[89] A. Corrigall,et al. A R59W mutation in human protoporphyrinogen oxidase results in decreased enzyme activity and is prevalent in South Africans with variegate porphyria , 1996, Nature Genetics.
[90] D. Bevan,et al. Mechanism of porphobilinogen synthase. Requirement of Zn2+ for enzyme activity. , 1980, The Journal of biological chemistry.
[91] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[92] J. Phillips,et al. Accelerated development of uroporphyria in mice heterozygous for a deletion at the uroporphyrinogen decarboxylase locus , 2001, Journal of biochemical and molecular toxicology.
[93] C. Beaumont,et al. Tissue-specific expression of porphobilinogen deaminase. Two isoenzymes from a single gene. , 1987, European journal of biochemistry.
[94] C. Hill,et al. Structural basis for tetrapyrrole coordination by uroporphyrinogen decarboxylase , 2003, The EMBO journal.
[95] G. Barnard,et al. Mechanism of porphobilinogen synthase. Possible role of essential thiol groups. , 1977, The Journal of biological chemistry.
[96] P. Romeo,et al. Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[97] H. Willard,et al. Assignment of human erythroid delta-aminolevulinate synthase (ALAS2) to a distal subregion of band Xp11.21 by PCR analysis of somatic cell hybrids containing X; autosome translocations. , 1992, Genomics.
[98] J. McGrath,et al. Homozygous variegate porphyria: identification of mutations on both alleles of the protoporphyrinogen oxidase gene in a severely affected proband. , 1998, The Journal of investigative dermatology.
[99] H. Bonkovsky,et al. Liver transplantation for erythropoietic protoporphyria liver disease , 2005, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[100] J. Kushner,et al. Hepatic siderosis and porphyria cutanea tarda: relation of iron excess to the metabolic defect. , 1977, Seminars in hematology.
[101] E. Cable,et al. Regulation of heme metabolism in rat hepatocytes and hepatocyte cell lines: delta-aminolevulinic acid synthase and heme oxygenase are regulated by different heme-dependent mechanisms. , 2000, Archives of biochemistry and biophysics.
[102] R. Desnick,et al. Human δ-aminolevulinate dehydratase: chromosomal localization to 9q34 by in situ hybridization , 1987, Human Genetics.
[103] G. Sutherland,et al. Erythroid 5-aminolevulinate synthase is located on the X chromosome. , 1990, American journal of human genetics.
[104] M. Wessling-Resnick. Iron transport. , 2000, Annual review of nutrition.
[105] A. Roberts,et al. An alternatively‐spliced exon in the 5′‐UTR of human ALAS1 mRNA inhibits translation and renders it resistant to haem‐mediated decay , 2005, FEBS letters.
[106] J. Deybach,et al. Molecular characterization of homozygous variegate porphyria. , 1998, Human molecular genetics.
[107] P. Romeo,et al. Structure of the gene for human uroporphyrinogen decarboxylase. , 1987, Nucleic acids research.
[108] J. Rose,et al. Human ferrochelatase: crystallization, characterization of the [2Fe-2S] cluster and determination that the enzyme is a homodimer. , 1999, Biochimica et biophysica acta.
[109] M. Fleming. The genetics of inherited sideroblastic anemias. , 2002, Seminars in hematology.
[110] D. Brown,et al. Analysis of uroporphyrinogen decarboxylase complementary DNAs in sporadic porphyria cutanea tarda. , 1993, Gastroenterology.